Cargando…
Response to Wagner et al.: phosphodiesterase-2—anti-adrenergic friend or hypertrophic foe in heart disease?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059414/ https://www.ncbi.nlm.nih.gov/pubmed/27678409 http://dx.doi.org/10.1007/s00210-016-1301-z |
| _version_ | 1782459400803319808 |
|---|---|
| author | Zoccarato, Anna Fields, Laura H. Zaccolo, Manuela |
| author_facet | Zoccarato, Anna Fields, Laura H. Zaccolo, Manuela |
| author_sort | Zoccarato, Anna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5059414 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50594142016-10-26 Response to Wagner et al.: phosphodiesterase-2—anti-adrenergic friend or hypertrophic foe in heart disease? Zoccarato, Anna Fields, Laura H. Zaccolo, Manuela Naunyn Schmiedebergs Arch Pharmacol Editorial Springer Berlin Heidelberg 2016-09-27 2016 /pmc/articles/PMC5059414/ /pubmed/27678409 http://dx.doi.org/10.1007/s00210-016-1301-z Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Editorial Zoccarato, Anna Fields, Laura H. Zaccolo, Manuela Response to Wagner et al.: phosphodiesterase-2—anti-adrenergic friend or hypertrophic foe in heart disease? |
| title | Response to Wagner et al.: phosphodiesterase-2—anti-adrenergic friend or hypertrophic foe in heart disease? |
| title_full | Response to Wagner et al.: phosphodiesterase-2—anti-adrenergic friend or hypertrophic foe in heart disease? |
| title_fullStr | Response to Wagner et al.: phosphodiesterase-2—anti-adrenergic friend or hypertrophic foe in heart disease? |
| title_full_unstemmed | Response to Wagner et al.: phosphodiesterase-2—anti-adrenergic friend or hypertrophic foe in heart disease? |
| title_short | Response to Wagner et al.: phosphodiesterase-2—anti-adrenergic friend or hypertrophic foe in heart disease? |
| title_sort | response to wagner et al.: phosphodiesterase-2—anti-adrenergic friend or hypertrophic foe in heart disease? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059414/ https://www.ncbi.nlm.nih.gov/pubmed/27678409 http://dx.doi.org/10.1007/s00210-016-1301-z |
| work_keys_str_mv | AT zoccaratoanna responsetowagneretalphosphodiesterase2antiadrenergicfriendorhypertrophicfoeinheartdisease AT fieldslaurah responsetowagneretalphosphodiesterase2antiadrenergicfriendorhypertrophicfoeinheartdisease AT zaccolomanuela responsetowagneretalphosphodiesterase2antiadrenergicfriendorhypertrophicfoeinheartdisease |